Some comparison if forum rules allow? Have you guys checked this Finnish company They too have diagnostic kits for colon cancer plus kits for gastrointestinal diseases. Biggest difference is that they are not in US market so valuation is much lower. But they have China and Russia in pipeline for gastropanel screenings which should be good for revenue and bottom line in the future. $EXAS
  • 3